555 related articles for article (PubMed ID: 36725964)
1. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.
Cambier S; Gouwy M; Proost P
Cell Mol Immunol; 2023 Mar; 20(3):217-251. PubMed ID: 36725964
[TBL] [Abstract][Full Text] [Related]
2. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
[TBL] [Abstract][Full Text] [Related]
3. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J
Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140
[TBL] [Abstract][Full Text] [Related]
4. The unique structural and functional features of CXCL12.
Janssens R; Struyf S; Proost P
Cell Mol Immunol; 2018 Apr; 15(4):299-311. PubMed ID: 29082918
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
6. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
7. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.
Matsuo Y; Ochi N; Sawai H; Yasuda A; Takahashi H; Funahashi H; Takeyama H; Tong Z; Guha S
Int J Cancer; 2009 Feb; 124(4):853-61. PubMed ID: 19035451
[TBL] [Abstract][Full Text] [Related]
8. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients.
Lisignoli G; Toneguzzi S; Piacentini A; Cristino S; Grassi F; Cavallo C; Facchini A
J Cell Physiol; 2006 Jan; 206(1):78-85. PubMed ID: 15965952
[TBL] [Abstract][Full Text] [Related]
9. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M
J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203
[TBL] [Abstract][Full Text] [Related]
10. Pathological roles of the homeostatic chemokine CXCL12.
Janssens R; Struyf S; Proost P
Cytokine Growth Factor Rev; 2018 Dec; 44():51-68. PubMed ID: 30396776
[TBL] [Abstract][Full Text] [Related]
11. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
12. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
Navarro J
Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
[TBL] [Abstract][Full Text] [Related]
13. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13.
Stich S; Loch A; Leinhase I; Neumann K; Kaps C; Sittinger M; Ringe J
Eur J Cell Biol; 2008 Jun; 87(6):365-76. PubMed ID: 18501472
[TBL] [Abstract][Full Text] [Related]
14. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
15. The dimeric form of CXCL12 binds to atypical chemokine receptor 1.
Gutjahr JC; Crawford KS; Jensen DR; Naik P; Peterson FC; Samson GPB; Legler DF; Duchene J; Veldkamp CT; Rot A; Volkman BF
Sci Signal; 2021 Aug; 14(696):. PubMed ID: 34404752
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8: An evolving chemokine.
Matsushima K; Yang D; Oppenheim JJ
Cytokine; 2022 May; 153():155828. PubMed ID: 35247648
[TBL] [Abstract][Full Text] [Related]
17. Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.
Janssens R; Mortier A; Boff D; Vanheule V; Gouwy M; Franck C; Larsen O; Rosenkilde MM; Van Damme J; Amaral FA; Teixeira MM; Struyf S; Proost P
Oncotarget; 2016 Sep; 7(38):62439-62459. PubMed ID: 27566567
[TBL] [Abstract][Full Text] [Related]
18. Chemokine patterning by glycosaminoglycans and interceptors.
Rot A
Front Biosci (Landmark Ed); 2010 Jan; 15(2):645-60. PubMed ID: 20036838
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.
Vacchini A; Mortier A; Proost P; Locati M; Metzemaekers M; Borroni EM
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486423
[TBL] [Abstract][Full Text] [Related]
20. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]